Matthew Halpern, MD
Dermatology · Wynnewood, PANPI 1538207600
Payments from drug & device makers
Across 107 payments — averaging $109.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron$10K
- AbbVie$467
- Johnson & Johnson$231
- Novartis$117
- Amgen$108
- Sun Pharmaceutical Industries Inc.$91
- plus $551 from 15 others
What the payments were for
- Consulting fees$9,83884%
- Travel & lodging$370%
- Food & beverage$1,85616%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron | 9 | $10,167 |
| AbbVie | 32 | $467 |
| Johnson & Johnson | 16 | $231 |
| Novartis | 5 | $117 |
| Amgen | 8 | $108 |
| Sun Pharmaceutical Industries Inc. | 5 | $91 |
| LEO Pharma Inc. | 5 | $84 |
| Incyte Corporation | 3 | $69 |
| Boehringer Ingelheim | 3 | $56 |
| Lilly USA, LLC | 3 | $50 |
| Organogenesis Inc. | 2 | $45 |
| Regeneron Healthcare Solutions, Inc. | 3 | $44 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $43 |
| UCB, Inc. | 2 | $34 |
| Galderma Laboratories, L.p. | 2 | $34 |
| Sanofi | 1 | $17 |
| Blueprint Medicines Corporation | 1 | $16 |
| Verrica Pharmaceuticals Inc. | 1 | $16 |
| Kyowa Kirin, Inc. | 1 | $15 |
| Genentech USA, Inc. | 1 | $14 |
| Mission Pharmacal Company | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LIBTAYO$15,414
How this compares
$11,731 in reported general payments places this provider in the 80th percentile of 626 dermatology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mupirocin | 166 | $1,085 |
| Doxycycline Hyclate | 23 | $196 |
| Amoxicillin | 39 | $58 |
| Cephalexin | 13 | $56 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Wynnewood
- Victoria WerthPhiladelphia$7.2M
- Laura FerrisPittsburgh$4.3M
- Joel GelfandPhiladelphia$3.6M
- Scott GottliebExton$3.4M
- Lawrence ParishPhiladelphia$2.9M
- Stephen SchleicherSugarloaf$2.3M
- Douglas KressWexford$2M
- Stephen HessPhiladelphia$1.7M
- Joe TungPittsburgh$1.5M
- Joslyn Sciacca-KirbyHershey$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.